{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:20:35Z","timestamp":1787019635618,"version":"build-2736575974"},"reference-count":47,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,23]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Steroid-refractory acute GVHD (SR-aGVHD) is a severe complication of allogeneic hematopoietic cell transplantation. While endothelial dysfunction is implicated in aGVHD pathophysiology, the status of the endothelium in patients with SR-aGVHD and the effect of the JAK1\/2 inhibitor ruxolitinib remain incompletely understood. This study aimed to characterize the endothelial damage phenotype induced by SR-aGVHD serum and to evaluate the potential modulatory effects of ruxolitinib. Human microvascular endothelial cells (HMEC-1) were exposed to serum from SR-aGVHD patients (n = 21) or healthy donors (C), with or without ruxolitinib (0.4 \u00b5M). Markers of endothelial activation (VCAM-1, ICAM-1), junctional integrity (VE-cadherin), prothrombotic state (VWF), apoptosis (cleaved caspase 3), and intracellular signalling (JAK-STAT and MAPK pathways) were analyzed by immunofluorescence and immunoblotting. Compared with C, SR-aGVHD serum caused increased VCAM-1 and ICAM-1 expression (P&amp;lt; .05 for both), reduced VE-cadherin (P&amp;lt; .01), elevated VWF production, and cleaved caspase 3 presence (P&amp;lt; .05 for both). These changes were associated with phosphorylation of STAT3 (P&amp;lt; .05), STAT1 (P&amp;lt; .05), and MAPK proteins (Erk1\/2, p38, SAP\/JNK, and cJun) (P&amp;lt; .05, all). Ruxolitinib treatment mitigated these responses, reducing adhesion molecule expression, restoring VE-cadherin localization, normalizing VWF production, and suppressing apoptosis. These protective effects were associated with inhibition of the activated JAK-STAT and MAPK signalling pathways. SR-aGVHD serum directly induces endothelial activation in vitro, promoting an inflammatory and prothrombotic phenotype. Ruxolitinib counteracts these effects, providing mechanistic insight into its therapeutic efficacy in SR-aGVHD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2026019704","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:57:32Z","timestamp":1777402652000},"page":"4379-4389","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Endothelial activation and damage associated with steroid-refractory aGVHD are counteracted by ruxolitinib"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4500-3884","authenticated-orcid":false,"given":"Blanca","family":"De Moner","sequence":"first","affiliation":[{"name":"1Hemostasis and Erythropathology Laboratory, Hematopathology, Department of Pathology, Biomedical Diagnostic Center, Hospital Cl\u00ednic de Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain"},{"name":"2Josep Carreras Leukaemia Research Institute, Hospital Cl\u00ednic de Barcelona, Universitat de Barcelona, Barcelona, Spain"},{"name":"3Barcelona Endothelium Team, Josep Carreras Leukemia Research Institute, Barcelona, Spain"},{"name":"4Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5934-7912","authenticated-orcid":false,"given":"Julia","family":"Martinez-Sanchez","sequence":"additional","affiliation":[{"name":"1Hemostasis and Erythropathology Laboratory, Hematopathology, Department of Pathology, Biomedical Diagnostic Center, Hospital Cl\u00ednic de Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Escribano-Serrat","sequence":"additional","affiliation":[{"name":"1Hemostasis and Erythropathology Laboratory, Hematopathology, Department of Pathology, Biomedical Diagnostic Center, Hospital Cl\u00ednic de Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0338-7514","authenticated-orcid":false,"given":"Ana Bel\u00e9n","family":"Moreno-Casta\u00f1o","sequence":"additional","affiliation":[{"name":"1Hemostasis and Erythropathology Laboratory, Hematopathology, Department of Pathology, Biomedical Diagnostic Center, Hospital Cl\u00ednic de Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain"},{"name":"4Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4777-9643","authenticated-orcid":false,"given":"Paola","family":"Charry","sequence":"additional","affiliation":[{"name":"5Apheresis and Cellular Therapy Unit, Hemotherapy and Hemostasis Department, Institute of Cancer and Blood Diseases, Hospital Cl\u00ednic de Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5445-4508","authenticated-orcid":false,"given":"Joan","family":"Cid","sequence":"additional","affiliation":[{"name":"5Apheresis and Cellular Therapy Unit, Hemotherapy and Hemostasis Department, Institute of Cancer and Blood Diseases, Hospital Cl\u00ednic de Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2593-833X","authenticated-orcid":false,"given":"Miquel","family":"Lozano","sequence":"additional","affiliation":[{"name":"5Apheresis and Cellular Therapy Unit, Hemotherapy and Hemostasis Department, Institute of Cancer and Blood Diseases, Hospital Cl\u00ednic de Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6236-7826","authenticated-orcid":false,"given":"Eduardo","family":"Arellano-Rodrigo","sequence":"additional","affiliation":[{"name":"6Hematology Department, Institute of Cancer and Blood Diseases, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Queralt","family":"Salas","sequence":"additional","affiliation":[{"name":"4Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona, Barcelona, Spain"},{"name":"7Hematopoietic Transplantation Unit, Hematology Department, Institute of Cancer and Blood Diseases, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Rovira","sequence":"additional","affiliation":[{"name":"4Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona, Barcelona, Spain"},{"name":"7Hematopoietic Transplantation Unit, Hematology Department, Institute of Cancer and Blood Diseases, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8401-7306","authenticated-orcid":false,"given":"Carmen","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"4Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona, Barcelona, Spain"},{"name":"7Hematopoietic Transplantation Unit, Hematology Department, Institute of Cancer and Blood Diseases, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6658-0381","authenticated-orcid":false,"given":"Gin\u00e9s","family":"Escolar","sequence":"additional","affiliation":[{"name":"1Hemostasis and Erythropathology Laboratory, Hematopathology, Department of Pathology, Biomedical Diagnostic Center, Hospital Cl\u00ednic de Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain"},{"name":"3Barcelona Endothelium Team, Josep Carreras Leukemia Research Institute, Barcelona, Spain"},{"name":"4Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enric","family":"Carreras","sequence":"additional","affiliation":[{"name":"2Josep Carreras Leukaemia Research Institute, Hospital Cl\u00ednic de Barcelona, Universitat de Barcelona, Barcelona, Spain"},{"name":"3Barcelona Endothelium Team, Josep Carreras Leukemia Research Institute, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"\u00c1lvarez-Larr\u00e1n","sequence":"additional","affiliation":[{"name":"4Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona, Barcelona, Spain"},{"name":"6Hematology Department, Institute of Cancer and Blood Diseases, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1122-0052","authenticated-orcid":false,"given":"Maribel","family":"Diaz-Ricart","sequence":"additional","affiliation":[{"name":"1Hemostasis and Erythropathology Laboratory, Hematopathology, Department of Pathology, Biomedical Diagnostic Center, Hospital Cl\u00ednic de Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain"},{"name":"3Barcelona Endothelium Team, Josep Carreras Leukemia Research Institute, Barcelona, Spain"},{"name":"4Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"issue":"9674","key":"2026062308480438000_bib1","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"The Lancet"},{"issue":"3","key":"2026062308480438000_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF02983793","article-title":"The pathophysiology of acute graft-versus-host disease","volume":"78","author":"Ferrara","year":"2003","journal-title":"Int J Hematol"},{"issue":"6","key":"2026062308480438000_bib3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nri3212","article-title":"Advances in graft-versus-host disease biology and therapy","volume":"12","author":"Blazar","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"16","key":"2026062308480438000_bib4","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1182\/blood-2010-10-312934","article-title":"The importance of neovascularization and its inhibition for allogeneic hematopoietic stem cell transplantation","volume":"117","author":"Penack","year":"2011","journal-title":"Blood"},{"issue":"12","key":"2026062308480438000_bib5","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/bmt.2011.65","article-title":"The role of the endothelium in the short-term complications of hematopoietic SCT","volume":"46","author":"Carreras","year":"2011","journal-title":"Bone Marrow Transpl"},{"issue":"7","key":"2026062308480438000_bib6","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.bbmt.2010.02.008","article-title":"Endothelial dysfunction after hematopoietic stem cell transplantation: role of the conditioning regimen and the type of transplantation","volume":"16","author":"Palomo","year":"2010","journal-title":"Biol Blood Marrow Transpl"},{"issue":"9","key":"2026062308480438000_bib7","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/bmt.2017.121","article-title":"Endothelial damage is aggravated in acute GvHD and could predict its development","volume":"52","author":"Mir","year":"2017","journal-title":"Bone Marrow Transpl"},{"issue":"10","key":"2026062308480438000_bib8","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nri2171","article-title":"Evolving functions of endothelial cells in inflammation","volume":"7","author":"Pober","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"22","key":"2026062308480438000_bib9","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"2026062308480438000_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2991\/chi.d.190317.001","article-title":"Endothelial dysfunction in hematopoietic cell transplantation","volume":"1","author":"Palomo","year":"2019","journal-title":"Clin Hematol Int"},{"issue":"8","key":"2026062308480438000_bib11","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3324\/haematol.2020.253716","article-title":"Endothelial damage and dysfunction in acute graft-versus-host disease","volume":"106","author":"Cordes","year":"2021","journal-title":"Haematologica"},{"key":"2026062308480438000_bib12","doi-asserted-by":"crossref","first-page":"601953","DOI":"10.1155\/2011\/601953","article-title":"Steroid-refractory acute GVHD: predictors and outcomes","volume":"2011","author":"Westin","year":"2011","journal-title":"Adv Hematol"},{"issue":"11","key":"2026062308480438000_bib13","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/j.bbmt.2019.07.017","article-title":"Outcomes and predictors of response in steroid-refractory acute graft-versus-host disease","volume":"25","author":"Rashidi","year":"2019","journal-title":"Biol Blood Marrow Transpl"},{"issue":"19","key":"2026062308480438000_bib14","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa1917635","article-title":"Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease","volume":"382","author":"Zeiser","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"2026062308480438000_bib15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2217\/imt-2017-0156","article-title":"Ruxolitinib for the treatment of patients with steroid-refractory GVHD: an introduction to the REACH trials","volume":"10","author":"Jagasia","year":"2018","journal-title":"Immunotherapy"},{"issue":"24","key":"2026062308480438000_bib16","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1182\/blood-2013-12-543736","article-title":"Activity of therapeutic JAK 1\/2 blockade in graft-versus-host disease","volume":"123","author":"Spoerl","year":"2014","journal-title":"Blood"},{"issue":"6","key":"2026062308480438000_bib17","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.bbmt.2017.12.797","article-title":"The role of Janus Kinase signaling in graft-versus-host disease and graft versus leukemia","volume":"24","author":"Schroeder","year":"2018","journal-title":"Biol Blood Marrow Transpl"},{"issue":"5","key":"2026062308480438000_bib18","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jtha.2023.01.027","article-title":"JAK-STAT inhibition reduces endothelial prothrombotic activation and leukocyte\u2013endothelial proadhesive interactions","volume":"21","author":"Beckman","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2026062308480438000_bib19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"issue":"1","key":"2026062308480438000_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-023-00438-1","article-title":"Acute graft-versus-host disease","volume":"9","author":"Malard","year":"2023","journal-title":"Nat Rev Dis Primer"},{"issue":"6","key":"2026062308480438000_bib21","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transpl"},{"issue":"17","key":"2026062308480438000_bib22","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood.2020007336","article-title":"Refractory acute graft-versus-host disease: a new working definition beyond corticosteroid refractoriness","volume":"136","author":"Mohty","year":"2020","journal-title":"Blood"},{"issue":"19","key":"2026062308480438000_bib23","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1182\/blood.2019000960","article-title":"How I treat steroid-refractory acute graft-versus-host disease","volume":"135","author":"Martin","year":"2020","journal-title":"Blood"},{"issue":"4","key":"2026062308480438000_bib24","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/bjh.16621","article-title":"Endothelial cell function and endothelial-related disorders following haematopoietic cell transplantation","volume":"190","author":"Hildebrandt","year":"2020","journal-title":"Br J Haematol"},{"key":"2026062308480438000_bib25","doi-asserted-by":"crossref","first-page":"1033490","DOI":"10.3389\/fimmu.2022.1033490","article-title":"Role of endothelial cells in graft-versus-host disease","volume":"13","author":"Neidemire-Colley","year":"2022","journal-title":"Front Immunol"},{"issue":"10","key":"2026062308480438000_bib27","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1038\/leu.2015.212","article-title":"Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey","volume":"29","author":"Zeiser","year":"2015","journal-title":"Leukemia"},{"issue":"5","key":"2026062308480438000_bib28","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00395-008-0733-0","article-title":"The role of inflammatory cytokines in endothelial dysfunction","volume":"103","author":"Zhang","year":"2008","journal-title":"Basic Res Cardiol"},{"issue":"4","key":"2026062308480438000_bib29","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/blood.2019000952","article-title":"Cytokines and costimulation in acute graft-versus-host disease","volume":"136","author":"Hill","year":"2020","journal-title":"Blood"},{"key":"2026062308480438000_bib30","doi-asserted-by":"crossref","first-page":"1525244","DOI":"10.3389\/fimmu.2024.1525244","article-title":"Targeting the chemokines in acute graft-versus-host disease","volume":"15","author":"Xu","year":"2024","journal-title":"Front Immunol"},{"key":"2026062308480438000_bib31","doi-asserted-by":"crossref","first-page":"708554","DOI":"10.3389\/fimmu.2021.708554","article-title":"Early endothelial activation in a mouse model of graft vs host disease following chemotherapy","volume":"12","author":"Pereira","year":"2021","journal-title":"Front Immunol"},{"key":"2026062308480438000_bib32","doi-asserted-by":"crossref","first-page":"5620314","DOI":"10.1155\/2017\/5620314","article-title":"The role of von Willebrand factor in vascular inflammation: from pathogenesis to targeted therapy","volume":"2017","author":"Gragnano","year":"2017","journal-title":"Mediators Inflamm"},{"issue":"3","key":"2026062308480438000_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5114\/polp.2021.109307","article-title":"Transplant-associated thrombotic microangiopathy","volume":"96","author":"Jarmoli\u0144ski","year":"2021","journal-title":"Pediatr Pol"},{"issue":"3","key":"2026062308480438000_bib34","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3390\/cancers15030680","article-title":"Endothelial dysfunction syndromes after allogeneic stem cell transplantation","volume":"15","author":"Vythoulkas","year":"2023","journal-title":"Cancers"},{"issue":"5","key":"2026062308480438000_bib35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/labinvest.3700541","article-title":"CD95 ligand-dependant endothelial cell death initiates oral mucosa damage in a murine model of acute graft versus host disease","volume":"87","author":"Deschaumes","year":"2007","journal-title":"Lab Invest"},{"issue":"6","key":"2026062308480438000_bib36","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1182\/blood-2011-02-334821","article-title":"Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system","volume":"118","author":"Luft","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2026062308480438000_bib37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbmt.2012.09.018","article-title":"Endothelial vulnerability and endothelial damage are associated with risk of graft-versus-host disease and response to steroid treatment","volume":"19","author":"Dietrich","year":"2013","journal-title":"Biol Blood Marrow Transpl"},{"issue":"10","key":"2026062308480438000_bib38","doi-asserted-by":"crossref","first-page":"e109799","DOI":"10.1371\/journal.pone.0109799","article-title":"Pharmacologic blockade of JAK1\/JAK2 reduces GvHD and preserves the graft-versus-leukemia effect","volume":"9","author":"Choi","year":"2014","journal-title":"PLoS One"},{"issue":"22","key":"2026062308480438000_bib39","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease \u2014 biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"2026062308480438000_bib40","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/ni.3691","article-title":"Mechanisms and consequences of Jak\u2013STAT signaling in the immune system","volume":"18","author":"Villarino","year":"2017","journal-title":"Nat Immunol"},{"issue":"1","key":"2026062308480438000_bib41","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2026062308480438000_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12964-018-0268-4","article-title":"Activation of the JAK\/STAT3 and PI3K\/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells","volume":"16","author":"Zegeye","year":"2018","journal-title":"Cell Commun Signal"},{"issue":"1","key":"2026062308480438000_bib43","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1742-4658.2009.07366.x","article-title":"ERK and cell death: mechanisms of ERK-induced cell death \u2013 apoptosis, autophagy and senescence","volume":"277","author":"Cagnol","year":"2010","journal-title":"FEBS J"},{"issue":"8","key":"2026062308480438000_bib44","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2694","article-title":"Signal integration by JNK and p38 MAPK pathways in cancer development","volume":"9","author":"Wagner","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"2026062308480438000_bib45","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.3390\/ijms22094980","article-title":"The role of JAK\/STAT molecular pathway in vascular remodeling associated with pulmonary hypertension","volume":"22","author":"Roger","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2026062308480438000_bib46","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41409-023-01912-w","article-title":"Mafosfamide, a cyclophosphamide analog, causes a proinflammatory response and increased permeability on endothelial cells in vitro","volume":"58","author":"Martinez-Sanchez","year":"2023","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"2026062308480438000_bib47","doi-asserted-by":"crossref","first-page":"100020","DOI":"10.1016\/j.bvth.2024.100020","article-title":"Vascular biomarkers reveal a unique toxicity profile of posttransplant cyclophosphamide: secondary analysis of BMT CTN 0402 and 1202","volume":"1","author":"Newell","year":"2024","journal-title":"Blood Vessel Thromb Hemost"},{"issue":"1","key":"2026062308480438000_bib48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jcyt.2023.10.008","article-title":"Endothelial Activation and Stress Index in adults undergoing allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based prophylaxis","volume":"26","author":"Escribano-Serrat","year":"2024","journal-title":"Cytotherapy"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/12\/4379\/2527847\/blooda_adv-2026-019704-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/12\/4379\/2527847\/blooda_adv-2026-019704-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:57:41Z","timestamp":1782219461000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/12\/4379\/568050\/Endothelial-activation-and-damage-associated-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,6,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2026019704","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,23]]},"published":{"date-parts":[[2026,6,15]]}}}